140 related articles for article (PubMed ID: 12397912)
1. A slow start to the new millennium. Zyvox, Concerta and Mifeprex headline the year.
Cornell S
Adv Nurse Pract; 2000 Dec; 8(12):62-4. PubMed ID: 12397912
[No Abstract] [Full Text] [Related]
2. Transdermal methylphenidate (Daytrana) for ADHD.
Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
[No Abstract] [Full Text] [Related]
3. Quillivant XR--an extended release oral suspension of methylphenidate.
Med Lett Drugs Ther; 2013 Feb; 55(1409):10-1. PubMed ID: 23381227
[No Abstract] [Full Text] [Related]
4. [Methylphenidate. A possibility for rare hyperactive children].
Rev Infirm; 2004 Sep; (103):39-40. PubMed ID: 15517803
[No Abstract] [Full Text] [Related]
5. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.
Strawn MN
J Contemp Health Law Policy; 2003; 19(2):495-520. PubMed ID: 14748255
[No Abstract] [Full Text] [Related]
6. The latest drugs on the FDA's radar.
Waldron T
Behav Healthc; 2006 Jun; 26(6):34-5. PubMed ID: 16833213
[No Abstract] [Full Text] [Related]
7. Linezolid.
Bell SG
Neonatal Netw; 2009; 28(3):187-92. PubMed ID: 19451082
[No Abstract] [Full Text] [Related]
8. Methylphenidate: its pharmacology and uses.
Challman TD; Lipsky JJ
Mayo Clin Proc; 2000 Jul; 75(7):711-21. PubMed ID: 10907387
[TBL] [Abstract][Full Text] [Related]
9. Human subjects research. Pediatric study of ADHD drug draws high-level public review.
Couzin J
Science; 2004 Aug; 305(5687):1088-9. PubMed ID: 15326317
[No Abstract] [Full Text] [Related]
10. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.
Leonard BE; McCartan D; White J; King DJ
Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851
[No Abstract] [Full Text] [Related]
11. Sustained-release methylphenidate: new preparations. New pharmaceutical forms: a slight advantage for a small number of children.
Prescrire Int; 2004 Dec; 13(74):203-6. PubMed ID: 15612099
[TBL] [Abstract][Full Text] [Related]
12. Azstarys (serdexmethylphenidate/dexmethylphenidate) for ADHD.
Med Lett Drugs Ther; 2021 Oct; 63(1634):157-159. PubMed ID: 34550957
[No Abstract] [Full Text] [Related]
13. New drug approvals in 2000.
Wynn RL
Gen Dent; 2001; 49(4):341-5. PubMed ID: 12016673
[No Abstract] [Full Text] [Related]
14. Summaries for patients. Linezolid.
Ann Intern Med; 2003 Jan; 138(2):I44. PubMed ID: 12529109
[No Abstract] [Full Text] [Related]
15. A new way to deliver psychiatric meds.
Levin-Epstein M
Behav Healthc; 2006 Aug; 26(8):22-3. PubMed ID: 16961036
[No Abstract] [Full Text] [Related]
16. Clip & save: drug chart. FDA-approved drugs to treat ADHD.
J Psychosoc Nurs Ment Health Serv; 2010 Mar; 48(3):9-10. PubMed ID: 20302260
[No Abstract] [Full Text] [Related]
17. The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder.
Han DH; Lee YS; Na C; Ahn JY; Chung US; Daniels MA; Haws CA; Renshaw PF
Compr Psychiatry; 2009; 50(3):251-6. PubMed ID: 19374970
[TBL] [Abstract][Full Text] [Related]
18. [Methylphenidate. A drug for attention deficit disorders to be used with precaution].
Taéron C
Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855
[No Abstract] [Full Text] [Related]
19. [Attention deficit hyperactivity disorder: pharmacological options that are not "Ritalin"].
Shmueli D; Gross-Tsur V
Harefuah; 2005 Aug; 144(8):572-6, 597. PubMed ID: 16146157
[TBL] [Abstract][Full Text] [Related]
20. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
[No Abstract] [Full Text] [Related]
[Next] [New Search]
